We demonstrated immunoreactivity for endothelins (ET)-1, -2, and -3 and for the precursor, big-ET-1, in the pulmonary &se neuroendocrine system (PDNES) of newbom cat, rat, hamster, and mouse. ET-& positive neuroepithelial bodies (NEB) were numerous in the intrapulmonary airways and the alveolar parenchyma. Single neuroendocrine c e l l s (NEC) were less often labeled and mainly localized in the larger bronchi. ET+rea&ve neuronal elements were rarely observed. The intensity and number of iaununostained NEB were highest for ET-3, followed in declining order by big-ET-1, ET-1, and ET-2. ET-like possessing NEB displayed interspecies Merences. We conclude that ET-3 represents a neuroendocrine form of the ET peptide family. NEB expressing several ET isoforms can be grouped into NEB contain-
Introduction
Pulmonary neuroendocrine cells (PNEC) secreting serotonin (5hydroxytryptamine; 5HT), peptides, and neuroendocrine markers (1-5) are a normal component of the vertebrate bronchopulmonary epithelium, arising at an early stage of embryological development and lasting throughout life (6,7). They occur in the airway epithelium of human and mammals either as solitary neuroendocrine cells (NEC) or as cell clusters, termed neuroepithelial bodies (NEB) (8) . Morphological similarities between pulmonary NEB and known chemoreceptors (e.g., aortic and carotid bodies) are striking. NEB are distinctly organoid and innervated cell corpuscles located strategically at airway bhrcations, possessing ultrastructurally heterogeneous secretory granules (1.9). Moreover, experimental studies have shown that NEB are sensitive to hypoxia and hypercapnia, acting via the central nervous system and/or by direct local modulation (10) (11) (12) (13) (14) . Being especially numerous and well developed in fe- tal and neonatal lungs (7,15), these cells may be important in pulmonary development and neonatal adaptation.
Since 5HT released by NEB on exposure to hypoxia plays a key role in the hitherto unsolved mechanism of hypoxia-induced pulmonary vasoconstriction, it appeared intriguing to investigate if endothelin (ET), the most potent vasoconstrictor peptide isolated to date (16, 17) , is present in the pulmonary diffuse neuroendocrine system (PDNES) of various animals. Immunocytochemistry was used to provide data on cellular distribution of ET-like peptides and on their co-localization with 5HT and/or calcitonin generelated peptide (CGRP).
Endothelin-1 (ET-1) is a 21-residue peptide originally isolated from cultured porcine endothelial cells (16.17) . It is produced through an unusual proteolytic processing of big-endothelin-1 (big-ET-l), a presumptive intermediate form (16) (17) (18) . Recently, the genes of three distinct EX (ET-1, ET-2, and ET-3) have been identified in various mammals, including human (16, 17, 19, 20) . ET-1 differs by two and six amino acids from ET-2 and ET-3, respectively, although the C-terminal structure is preserved among all three isoforms (19) (Figure 1 ). They are assumed to possess different biological activities and receptors (19) . Endothelins do not belong to any reported mammalian peptide family but exhibit structural and functional homology with certain snake toxins (16, 17, 21) that produce coronary vasoconstriction. In addition to its potent and sus- tained vasoconstrictorlpressor effects, ET has extravascular effects, including stimulation of the contractile activity of bronchial and intestinal smooth muscle, neurotransmitter action in the central nervous system, and cell mitogenic properties (22) (23) (24) (25) . In the lung, ET-binding sites have been detected in vascular and non-vascular smooth muscle, nerves, and alveolar septa (26) (27) (28) (29) . Radioimmunoassays (RIA) have revealed high ET concentrations in porcine and rat lung (30, 31) and in canine pulmonary epithelial cell cultures (32) . The peptide and its mRNA have been demonstrated in airway epithelial cells (33, 34) , which were, however, not further characterized. Only Giaid and colleagues (35) identified big-ET-1-and ET-1-producing cells in human lung.
In the present study we investigated immunocytochemically the occurrence of big-ET-1, ET-1, ET-2, and ET-3 and their relationship to the PNEC in newborn cat, rat, hamster, and mouse lung.
Materials and Methods
T i u e Proassing. Samples of neonatal lungs (1 day to 1 week of age) were obtained from cats (n = 4). rats (n = 3), hamsters (n = 4). and mice (n = 3). All animals were anesthetized with pentobarbital sodium (35 mglkg body weight, IP). After perfusion with heparinized physiological saline (20 Ulml), the lungs were fixed by gentle intratracheal injection of Bouin's fluid or 10% buffered formalin. Next, tissues were divided and immersed in the same fixatives for 6-12 hr. All material was processed to paraffh wax.
Antisera. The rabbit CGRP antiserum RPN.1842 (Amersham; hole, UK) was raised against synthetic rat CGRP conjugated to bovine serum albumin (BSA) with glutaraldehyde. Crossreactivity was detected with rat and human CGRP but not with calcitonin, amylin, somatostatin, or substance P. The antiserum to 5HT (NA-08-324) (Cambridge Research Biochemicals; Cheshire, UK) was produced in rabbits immunized with the ubiquitous 5HT molecule coupled to BSA with formaldehyde. The antiserum crossreacted fully with tryptamine but not with melatonin, L-tryptophan, 5-hydroxytryptophan, epinephrine, norepinephrine, or tetragastrin. The rabbit ET antibodies big-ET-1 (RAS-6912-N), ET-1 (RAS-6901-N), ET-2 (RAS-6910-N) and ET-3 (RAS-6911-N) (Peninsula Laboratories; St Helens, UK) were raised in rabbits against the respective human antigens conjugated to BSA with glutaraldehyde. The results of specificity tests done by the distributor correspond to those of our liquid-phase absorptions (Xble 1). In addition, no crossreactivity was detected with sarafotoxin S6b, brain nauiuretic peptide, or angiotensin 11.
Immunocytochemistry. Paraffin sections (4 pm thick) were mounted on poly-L-lysine-coated slides (P 8920) (Sigma; St Louis, MO). After drying overnight at 37T, sections were dewaxed and immersed in methanol containing 0.3% HzOz for 30 min to quench any endogenous peroxidase activity. After blocking of nonspecific background staining with 3% normal swine serum (X901) (Dako; Glostrup, Denmark) for 30 min at room temperature (RT), the avidin-biotin-peroxidase complex (ABC) method (36) was used. Since a dilution of 1:500 with PBS gives the best signal-tonoise ratio for 5HT. CGRP, big-ET-1, ET-1, and ET-3, all primary antibodies were diluted as such and incubated overnight in a moist chamber at 4°C. The preparations were then washed with PBS and incubated with biotinylated swine anti-rabbit immunoglobulins (E353; Dako) (diluted 1:lOO) for 30-45 min followed, after washing in PBS, by the third layer, i.e., ABC ComplexlHRP (K355; Dako) (diluted 1:200) for 60 min at RT. The peroxidase activity was localized with a solution of PBS containing 0.05% 3,3'diaminobenzidine and 0.03% HzOz for 5-10 min. After final washing, sections were counterstained with Mayer's hematoxylin, dehydrated, cleared, mounted in DePeX, and examined with the Leitz CBA 8000 color image analyzing system. Photomicrographs were taken with a Leitz Vario-Orthomat camera system.
To control method specificity, some sections were incubated with nonimmune rabbit serum instead of the primary antiserum, and, where applicable, one of the stages in the ABC procedure was omitted. The specificity of each ET antibody was determined by pre-absorption for 18 hr at RT with the respective synthetic antigen at 10 nmollml of diluted antiserum (Table 1) .
CO-localization Studies. To determine whether distinct ET peptides coexist in the same NEB as well as with 5HT and/or CGRP, series of serial sections were mounted. In one sequence every second section was incubated with big-ET-1 antiserum, and the remaining sections were alternately immunostained with ET-1, ET-2, ET-3, SHT, or CGRP antibodies. The pro- cedure was repeated for evcry other antiserum on different series of serial tissue preparations.
The production and characteristics of the 5HT and CGRP antisera have already been described (see above) (14.37). The specificity of both antisera was examined by means of liquid-phase absorption with 10 nmollml of the respective antigen (Eble 1). Crossreactivities between the different antibodies were tested by the alternate addition of 10 nmol/ml of the other peptides (Eble 1). All synthetic antigens were purchased from Peninsula Laboratories.
Results

Immunocytochemistry
In lung tissue sections of newborn cat, rat, hamster, and mouse, immunoreactivity was seen for all endothelin (big-ET-1, ET-1, ET-2, ET-3) antisera used. Although morphological details were better preserved with Bouin's fluid, both fixatives yielded the same immunopositivity.
The most striking feature was the immunolabeling of PNEC. Whereas there was no topographical preference of ET antibodies for airway to alveolar neuroepithelial bodies or vice versa, they differed in four staining properties. The immunoreaction intensity of NEB was highest for ET-3, followed in declining order by big-ET-1, ET-1, and ET-2 (Figures 2A-2C) . Moreover, ET-3-and ET-2-positive NEB formed the largest and smallest proportion, respectively, whereas big-ET-1 and ET-1 containing NEB were moderately and almost equally present. The ET-2 antibody appeared to give higher background staining than the other ET antisera (Figures 2A-2C) . The most abundant staining was observed in lungs of cats, followed by rats, hamsters, and mice.
ET-like-expressing NEB were apparently distributed along large and small airways (Figures 2A-2C ) and in the alveolar parenchyma (Figures 3, 4 , and 5B). Prominent blood capillaries were usually found in their neighborhood (Figures 3 and 5B ). Immunolabeled NEB were most numerous in the bronchioli and occurred frequently at airway bifurcations (Figures 2A-2C) . Morphologically, the positive NEB exhibited fan-, crater-, or cone-like configurations ( Figures  2A-2C , 3,4, and 5B). Depending on the investigated species (38) , NEB consisted of one or several layers of cylindrical to cuboidal cells, arranged more or less regularly and reaching from the basement membrane to the airway lumen. The cell cytoplasm was distinctly immunostained, whereas the oval nuclei, oriented parallel to the longitudinal cell axis, reacted only with the ET-3 antiserum (Figure 4) .
Positive NEC were found in the epithelium for the proximal bronchi and were often triangular in shape, exhibiting an apical process towards the airway lumen.
No immunoreaction was noted in other epithelial cell types (Figures 2A-2C, 6, and 7) .
Endothelial cells were stained with big-ET-1, ET-1, and/or ET-2 antisera (Figure 6) . Vascular and non-vascular smooth muscle cells revealed a diffuse immunoreaction for all ET reactants, but were less obvious for ET-3 (Figure 7) . Reactivity was never observed in cartilage or in connective tissues (Figures 2A-2C, 6, and 7) , although ET-3-positive nerve fibers or intrapulmonary ganglion cells were occasionally seen.
Pre-absorption of each ET antiserum with its respective synthetic antigen ( Table 1 ) and omission of one step in the ABC method, or incubation of lung sections with non-immune serum instead of the first-layer antiserum, abolished all immunostaining. These results confirm the specificity of each ET antiserum used.
CO-LocaLization
In addition to NEB stained for only one ET immunoreactant, light optical investigation of serial sections revealed two main types of double-labeled NEB. The first reacted positively with bigET-1, ET-1, and ET-2 (Figures 2A-2C ), the second with ET-3 (and ET-2). Although ET-2 immunoreactivity was detected in both classes, it was preferentially present in the first type. Only exceptionally, the same NEB displayed staining for each antiserum. Moreover, ETlike immunoreactivity occurred in a high proportion of NEB producing either 5HT, CGRP, or both ( Figures 5A-5C ).
The results of the pre-absorption tests are listed in Table 1 . Although crossreactivities among the investigated antibodies usually did not affect staining, pre-incubation with synthetic ET-2 peptide gave only afaint immunoreaction in the case of ET-1 and ET-3 antisera. The ET-2 antibody, on the other hand, crossreacted with all others.
Discussion
To the best of our knowledge, this is the first study to demonstrate cell localization of big-ET-1, ET-1, ET-2, and ET-3 immunoreactants in pulmonary neuroendocrine cells and in other lung tissue components of newbom cat, rat, hamster, and mouse.
The immunostaining pattern in NEB suggests strongly that actual synthesis of these peptides is taking place rather than receptor interactions. Therefore, it confirms a recent in situ hybridization study (35) , which showed ET-1 and its precursor to be elaborated by PNEC. The nuclear staining observed with the ET-3 antiserum may reflect the concentration of cytoplasmic proteins around the nuclear membrane during tissue processing, or the (artifactually or otherwise) occurrence of such proteins in the nucleus itself. Hitherto, no dense secretory granules, in which pre-synthesized active substances such as peptides are stored, could be found in any of the ET-like-positive tissue components, implying that secretion is regulated at the level of peptide synthesis (i.e., transcription and/or translation) and not at the level of the release mechanism The variation in number and intensity of reactive NEB observed not only among cat, rat, hamster, and mouse, but also in each species separately may be explained by interspecies differences and various antigen concentrations, respectively.
Our finding of ET-3 expressing NEB being the most abundantly and intensively labeled does not entirely parallel the reported higher pulmonary concentration of ET-1 immunoreactivity compared with . This can be explained by the use of adult rat lungs in that study. An important "dilution" of PNEC indeed occurs in lung tissue during growth and differentiation (2), resulting in eventual predominance of other tissue elements. As the ET isoforms are also coded for by different genes (19) and possibly are independently regulated, differential expression might occur not only in specific tissues andlor tissue components but also between distinct life (16) (17) (18) 39 ). ., c a periods and anima! species. However, ampler staining for ET-3 as compared with ET-1 in the present study may be simply due to different affinities of the respective antisera for NEB in question. Therefore, although relative immunostaining appears to suggest that ET-3 is greater than ET-1, absolute quantitation of their levels in neonatal lung tissue requires RIA with appropriate standard curves based on known amounts of these peptides.
-4
The comparable immunoreactivities for ET-1 and its precursor peptide in NEB of newborn animals may imply a balanced conversion from bigET-1 to ET-1 at this stage (40, 41) . The precise nature of this equilibrium awaits elucidation of the electron microscopic localization of the different ET forms and a more detailed analysis of their synthesis and secretion process.
The crossreaction of the ET-2 antiserum with a!! other ET iso- forms, the weak immunoreactivity in NEB, and the high background staining suggest that this antibody is of too low a specificity and that little can be concluded on the basis of results produced by it. Alternative interpretations for the observed staining differences of endocrine epithelial cells are: (a) crossreactivity of ET antibodies with similar epitopes in other as yet undefined molecules; (b) separate processing of ET peptides in different neuroepithelial cell clusters; (c) various rates of catabolism by lung tissue peptidases; or (d) uptake of ET from mtemal sources. Indeed, the rapid elimination of ET-1 from the circulation might be due to trapping of the intact peptide by parenchymal organs, such as lungs, kidneys, liver, and spleen (18). Still. specific inactivating and/or metabolizing ET peptidases remain to be demonstrated in these ET-clearing tissues and in the biological target tissues and/or cells.
Non-endocrine epithelial cell staining does not occur in the investigated newborn mammals, although ET mRNA has been demonstrated (34) and the peptide has been shown in rats and mice at this site (33) .
The specific ET-like immunostaining pattern of endocrine epithelial (for all isopeptides, including the precursor), endothelial (for big-ET-1, ET-1, and ET-2), and smooth muscle (for all forms, but ET-3 only faintly) cells, in addition to the different structures and pharmacological activities, point to various physiological roles of ET peptides in these tissue elements (18, 19, 31, 42) . ET-1 is considered to regulate mainly vascular and airway smooth muscle contractility (22, 43) . This agrees well with the observation that ET-1 is predominantly present in endothelial and smooth muscle cells. The finding of big-ET-1 expression in both cell types might indicate that conversion from big-ET-1 to ET-1 is taking place (40, 41) . The expression and role of ET-2 have not yet been convincingly demonstrated in any tissue (18) . In addition, this study cannot help to unravel its pulmonary function, as crossreactivities do exist between ET-2 and the other antisera. ET-3 is a much weaker constrictor than ET-1 and has been proposed to be a neuroendocrine form of ET (19J1.44) . This coincides with the reported presence here of ET-3 in NEB and some neuronal elements.
ET peptides may exert their activity by interacting with different receptor subtypes (19) . In vivo, ET appeared to exert its effects in the vicinity of its release (45) . Moreover, ET mRNA is synthesized in close proximity to ET-binding sites in many organs (34) . Both findings suggest a paracrine mode of action of this peptide. NEB are often found in the environs of vascular smooth muscle cells and endothelial cells, which all possess ET-binding sites (26, 29, 34) . Therefore, these cells are potential targets for the local actions of NEB-derived E%. However, in kidney and lung, ET receptors have also been discovered in the absence of ET mRNA sites, implying an action of ET from the bloodstream or from neurons (16, 17, 26, 34) . Consequently, ET-like-possessing NEB may also have endocrine and/or neurocrine effects.
The existence of two immunohistochemical NEB population types, displaying bigET-1 and ET-1, on the one hand, and ET-3, on the other, parallels the autoradiographic finding of two receptor sets with affinities for ET-1 and ET-2, and ET-3, respectively in a variety of tissues (46) (47) (48) . Further investigation should be carried out concerning a possible functional correlation between synthesis and receptor site. However, because of the poor specificity of the ET-2 antiserum little can be concluded on the basis of results produced by it. In further studies, this antibody should be discarded as not good enough to yield publishable data.
Although representing only a subset of 5HTor CGRP-immunoreactive NEB, the overall distribution of ET isoforms is strikingly similar (13,14,37). These immunocytochemical results suggest NEB to be a storehouse of heterogeneous biologically active substances, such as neurotransmitters and/or peptide hormones, which are functionally interacting and involved in a multitude of effects. The role of 5HT stored in PNEC is not entirely clear yet. It may be that the 5HT secreted during hypoxia (10.11) causes a vasoconstrictor response, shunting blood from poorly to better oxygenated and ventilated portions of the lung. Therefore, in addition to central and peripheral chemoreceptors, locally acting intrapulmonary chemoreceptors responsible for final adjustment of the ventilation-to-perfusion ratios might exist. CGRP, a 37 amino-acid product encoded by mRNA transcribed from the calcitonin gene, is a peptide with potent vasodilatory (49) and bronchoconstrictor effects (50) . In the lung, CGRP was found in neuronal and endocrine cells (37, 51) .
Considering the potent pulmonary actions of ET, 5HT, and CGRP, their demonstrated coexistence in pulmonary NEB may be crucial in regulating the supposed role(s) of these endocrine cell corpuscles as secretory neuro(chemo)receptors involved in lung, growth, mucosal secretion, and vaso-and/or bronchomotor tone in response to alterations in airway gas composition (8,lO-12).
In conclusion, this study represents the first comprehensive morphological mapping and immunocytochemical evidence that big-ET-1, ET-1, and ET-3 are authentic products of PNEC in newborn cat, rat, hamster, and mouse. These findings further illustrate the potentially far-reaching role of endothelins in lung cell biology.
